Evidence map›Paper›PMID 35507695›Full record

ArticleACS applied materials & interfaces2022

Caffeine Encapsulation in Metal Organic Framework MIL-53(Al) at Pilot Plant Scale for Preparation of Polyamide Textile Fibers with Cosmetic Properties.

Beatriz Zornoza, César Rubio, Elena Piera, Miguel A Caballero, Daniel Julve, Jorge Pérez, Carlos Téllez, Joaquín Coronas

Open access · hybridAbstract read
In one paragraph

Article in ACS applied materials & interfaces, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.4field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Beatriz ZornozaChemical and Environmental Engineering Department, Universidad de Zaragoza, 50018, Zaragoza, Spain.
César RubioInstituto de Nanociencia y Materiales de Aragón (INMA), Universidad de Zaragoza-CSIC, 50009, Zaragoza, Spain.
Elena PieraResearch and Development Department. Nurel S.A., Ctra. Barcelona km 329, 50016, Zaragoza, Spain.
Miguel A CaballeroResearch and Development Department. Nurel S.A., Ctra. Barcelona km 329, 50016, Zaragoza, Spain.
Daniel JulveIndustrias Químicas del Ebro (IQE) S. A. Grupo IQE, 50016, Zaragoza, Spain.
Jorge PérezIndustrias Químicas del Ebro (IQE) S. A. Grupo IQE, 50016, Zaragoza, Spain.
Carlos TéllezInstituto de Nanociencia y Materiales de Aragón (INMA), Universidad de Zaragoza-CSIC, 50009, Zaragoza, Spain.ORCID 0000-0002-4954-1188
Joaquín CoronasInstituto de Nanociencia y Materiales de Aragón (INMA), Universidad de Zaragoza-CSIC, 50009, Zaragoza, Spain.ORCID 0000-0003-1512-4500
Universidad de Zaragoza · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Currently in the marketplace, we can find clothing items able to release skin-friendly ingredients while wearing them. These innovative products with high-added value are based on microencapsulation technology. In this work, due to its lightness, flexibility, porosity, chemical affinity and adsorption capacity, metal-organic framework (MOF) MIL-53(Al) was the selected microcapsule to be synthesized at a large scale and subsequent caffeine encapsulation. The synthesis conditions (molar ratio of reactants, solvents used, reaction time, temperature, pressure reached in the reactor and activation treatment to enhance the encapsulation capacity) were optimized by screening various scaling-up reactor volumes (from lab-scale of 40 mL to pilot plant production of 3.75 L). Two types of Al salts (Al(NO

Indexed as

CosmeticsMetal-Organic FrameworksCaffeineCapsulesNylonsTextilesCaffeineCapsulesCosmeticsMetal-Organic FrameworksNylonscaffeinecarboxylate ligandMetal organic frameworkmicroencapsulationMIL-53(Al)polyamidescaled-up synthesistextile fiber

Identifiers

PMID35507695
PMCPMC9121351
OpenAlexW4229067059

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.